Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recognition and management of clinically significant drug-drug interactions between antiretrovirals and co-medications in a cohort of people living with HIV in rural Tanzania: a prospective questionnaire-based study.
Kuemmerle A, Sikalengo G, Vanobberghen F, Ndege RC, Foe G, Schlaeppi C, Burri C, Battegay M, Paris DH, Glass TR, Weisser M, Marzolini C; KIULARCO Study Group. Kuemmerle A, et al. J Antimicrob Chemother. 2021 Sep 15;76(10):2681-2689. doi: 10.1093/jac/dkab254. J Antimicrob Chemother. 2021. PMID: 34337653
Prevalence and management of drug-drug interactions with antiretroviral treatment in 2069 people living with HIV in rural Tanzania: a prospective cohort study.
Schlaeppi C, Vanobberghen F, Sikalengo G, Glass TR, Ndege RC, Foe G, Kuemmerle A, Paris DH, Battegay M, Marzolini C, Weisser M; Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) study group. Schlaeppi C, et al. Among authors: kuemmerle a. HIV Med. 2020 Jan;21(1):53-63. doi: 10.1111/hiv.12801. Epub 2019 Sep 18. HIV Med. 2020. PMID: 31532898 Free PMC article.
Efficacy and safety of intravenous ferric carboxymaltose compared with oral iron for the treatment of iron deficiency anaemia in women after childbirth in Tanzania: a parallel-group, open-label, randomised controlled phase 3 trial.
Vanobberghen F, Lweno O, Kuemmerle A, Mwebi KD, Asilia P, Issa A, Simon B, Mswata S, Schmidlin S, Glass TR, Abdulla S, Daubenberger C, Tanner M, Meyer-Monard S. Vanobberghen F, et al. Among authors: kuemmerle a. Lancet Glob Health. 2021 Feb;9(2):e189-e198. doi: 10.1016/S2214-109X(20)30448-4. Epub 2020 Nov 24. Lancet Glob Health. 2021. PMID: 33245866 Free article. Clinical Trial.
Development of a pharmacovigilance system in a resource-limited country: the experience of the Democratic Republic of Congo.
Nzolo D, Kuemmerle A, Lula Y, Ntamabyaliro N, Engo A, Mvete B, Liwono J, Lusakibanza M, Mesia G, Burri C, Mampunza S, Tona G. Nzolo D, et al. Among authors: kuemmerle a. Ther Adv Drug Saf. 2019 Jul 16;10:2042098619864853. doi: 10.1177/2042098619864853. eCollection 2019. Ther Adv Drug Saf. 2019. PMID: 31360433 Free PMC article. Review.
Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
Kuemmerle A, Schmid C, Bernhard S, Kande V, Mutombo W, Ilunga M, Lumpungu I, Mutanda S, Nganzobo P, Tete DN, Kisala M, Burri C, Blesson S, Valverde Mordt O. Kuemmerle A, et al. PLoS Negl Trop Dis. 2021 Nov 8;15(11):e0009903. doi: 10.1371/journal.pntd.0009903. eCollection 2021 Nov. PLoS Negl Trop Dis. 2021. PMID: 34748572 Free PMC article. Clinical Trial.
In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.
Schmid C, Kuemmerle A, Blum J, Ghabri S, Kande V, Mutombo W, Ilunga M, Lumpungu I, Mutanda S, Nganzobo P, Tete D, Mubwa N, Kisala M, Blesson S, Mordt OV. Schmid C, et al. Among authors: kuemmerle a. PLoS Negl Trop Dis. 2012;6(11):e1920. doi: 10.1371/journal.pntd.0001920. Epub 2012 Nov 29. PLoS Negl Trop Dis. 2012. PMID: 23209861 Free PMC article. Clinical Trial.
Prescription of concomitant medications in patients treated with Nifurtimox Eflornithine Combination Therapy (NECT) for T.b. gambiense second stage sleeping sickness in the Democratic Republic of the Congo.
Kuemmerle A, Schmid C, Kande V, Mutombo W, Ilunga M, Lumpungu I, Mutanda S, Nganzobo P, Ngolo D, Kisala M, Valverde Mordt O. Kuemmerle A, et al. PLoS Negl Trop Dis. 2020 Jan 27;14(1):e0008028. doi: 10.1371/journal.pntd.0008028. eCollection 2020 Jan. PLoS Negl Trop Dis. 2020. PMID: 31986140 Free PMC article. Clinical Trial.
29 results